Thomas S Hayday
Overview
Explore the profile of Thomas S Hayday including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vantourout P, Eum J, Conde Poole M, Hayday T, Laing A, Hussain K, et al.
Sci Adv
. 2023 Dec;
9(49):eadj6174.
PMID: 38055824
Clonotypic αβ T cell responses to cargoes presented by major histocompatibility complex (MHC), MR1, or CD1 proteins underpin adaptive immunity. Those responses are mostly mediated by complementarity-determining region 3 motifs...
2.
Joseph M, Wu Y, Dannebaum R, Rubelt F, Zlatareva I, Lorenc A, et al.
Proc Natl Acad Sci U S A
. 2022 Aug;
119(34):e2201541119.
PMID: 35943978
Whereas pathogen-specific T and B cells are a primary focus of interest during infectious disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader...
3.
Del Molino Del Barrio I, Hayday T, Laing A, Hayday A, Di Rosa F
Cytometry A
. 2021 Nov;
103(2):117-126.
PMID: 34811890
Here we consider how high-content flow cytometric methodology at appropriate scale and throughput rapidly provided meaningful biological data in our recent studies of COVID-19, which we discuss in the context...
4.
Monin L, Laing A, Munoz-Ruiz M, McKenzie D, Del Molino Del Barrio I, Alaguthurai T, et al.
Lancet Oncol
. 2021 Apr;
22(6):765-778.
PMID: 33930323
Background: The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (Pfizer-BioNTech) vaccine in...
5.
Abdul-Jawad S, Bau L, Alaguthurai T, Del Molino Del Barrio I, Laing A, Hayday T, et al.
Cancer Cell
. 2021 Jan;
39(2):257-275.e6.
PMID: 33476581
Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type,...
6.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Nov;
26(12):1951.
PMID: 33247289
A Correction to this paper has been published: https://doi.org/10.1038/s41591-020-01186-5.
7.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Sep;
26(10):1663.
PMID: 32908251
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
8.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Aug;
26(10):1623-1635.
PMID: 32807934
Improved understanding and management of COVID-19, a potentially life-threatening disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end, we have identified a core peripheral...
9.
Upton N, Hayday T, James L
Methods Mol Biol
. 2019 Jun;
2020:165-174.
PMID: 31177499
The important role of the local mucosal environment in both the initiation and progression of allergic disease is well established. Analysis of tissue-resident lymphocyte subsets by flow cytometry requires isolation...